Furthermore, the application of GSK‐3β inhibitor, 9‐ING‐41, significantly alleviated the AD‐like pathologies and cognitive deficits in ApoE4‐T2DM mice. This evidence concerns the gene APOE and type 2 diabetes mellitus.